Company Filing History:
10 out of 1,935 
3 out of 1,163 
1 out of 15,541 
Years Active: 2015-2023
Title: **Innovative Contributions of Edwin John Weeber**
Introduction
Edwin John Weeber, an accomplished inventor based in Apollo Beach, Florida, has significantly contributed to the field of neuroscience through his innovative research and developments. With a portfolio of ten patents, his work focuses primarily on animal models for understanding neurological disorders, including Angelman Syndrome.
Latest Patents
Among his latest inventions, one notable patent is the "Animal model of Angelman Syndrome". This invention involves non-human animals genetically modified to lack the entire E3 ubiquitin ligase (Ube3a) gene. These models are instrumental for researchers as they mimic the condition, allowing for the assessment of potential therapeutic agents' effects on the disease.
Another significant patent is concerning "Drug-induced activation of the Reelin signaling system". This patent discloses compounds designed to activate this signaling system aimed at treating various neurological disorders. The invention also encompasses methods for activating lipoprotein receptors, such as ApoER2 or VLDLR, showcasing his dedication to improving treatment options for complex health challenges.
Career Highlights
Edwin has had a dynamic career, working at prominent institutions like the University of South Florida and Vanderbilt University. His association with these institutions has facilitated significant advancements in research relating to genetics and neurological disorders.
Collaborations
Throughout his career, Edwin has collaborated with talented professionals, including Melinda Marie Peters and Lisa Zhao. These partnerships have fostered an environment that encourages cross-disciplinary insights and innovative problem-solving in the field of neuroscience.
Conclusion
Edwin John Weeber stands out as a pioneer in the field of neurological research, with a solid foundation of patents that advance our understanding and treatment of complex disorders. His innovative work continues to inspire future research and contribute to the development of potential therapies that could significantly impact many lives.